Yes. The issue affects the Asthma Medication Ratio (AMR) measure used in commercial HMO and commercial ACO reporting.
The Asthma Controller Medications List incorrectly included codes for nebulizer medications. NCQA issued a correction and has removed the codes from the NDC list. An updated version of the MLD was released on February 8, and IHA released a communication to stakeholders on February 9.
Next Steps for VBP4P
NCQA has identified next steps:
- Self-reporting physician organizations and health plans that program AMR are required to download the updated HEDIS® 2018 Medication List Directory (MLD) of NDC codes. NCQA certified auditors have been notified and will review your corrected code during your VBP4P audit.
- NCQA certified vendors are required to submit an attestation that the certified vendors have removed the codes from their software.
- If your organization contracts with an NCQA certified vendor or a vendor seeking certification, they have been notified and asked to incorporate this update when programming your MY 2017 results.
If you contract with a noncertified vendor, notify your vendor about this change immediately.
ALL 2017